These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3526183)

  • 1. [Ceftazidime in the treatment of infections in intensive care. Experience with 20 clinical cases].
    Liverta E; Pasquetti G; Carnevali M; Bellucci MC
    Minerva Anestesiol; 1986; 52(1-2):47-9. PubMed ID: 3526183
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Regazzi MB; Maurelli M; Calvi M; Mapelli A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):457-9. PubMed ID: 3536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime in febrile SLE patients.
    Boey ML; Feng PH
    Singapore Med J; 1988 Aug; 29(4):393-5. PubMed ID: 3074518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reevaluation of current antimicrobials. Ceftazidime].
    Urabe A; Inamatsu T
    Jpn J Antibiot; 1994 Aug; 47(8):983-90. PubMed ID: 7523743
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime (Fortaz).
    Med Lett Drugs Ther; 1985 Oct; 27(698):85-7. PubMed ID: 3900663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacterial infections in cancer patients].
    Krankenpfl J; 2005; 43(1-3):42-3. PubMed ID: 15912833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a new beta-lactam antibiotic, ceftazidime, in the neurosurgical intensive care unit. Preliminary observations].
    Ravelli V; Buonaguidi R; Lutzemberger L
    Minerva Anestesiol; 1985 Sep; 51(9):471-3. PubMed ID: 3913880
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with ceftazidime in the management of a variety of gram-negative infections.
    Spantideas A
    Chemioterapia; 1987 Jun; 6(2 Suppl):377-8. PubMed ID: 3334580
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity.
    Harper PB
    Clin Ther; 1984; 6(4):411-24. PubMed ID: 6432324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
    Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
    Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime: a new broad spectrum cephalosporin.
    Moellering RC
    Pediatr Infect Dis; 1985; 4(4):390-3. PubMed ID: 3895178
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ceftazidime: review of the microbiological and clinical experience].
    Arosio E; Pancera P; Montesi G
    Recenti Prog Med; 1985 Dec; 76(12):635-42. PubMed ID: 3914016
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of ceftazidime in the treatment of osteomyelitis and osteoarthritis.
    De Bastiani G; Nogarin L; Molinaroli F; Bragantini A; Fostini R
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):677-9. PubMed ID: 3546169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of 42 patients treated with ceftazidime].
    Farci G; Laconi R; Lai ME; Balestrieri A
    Clin Ter; 1985 Nov; 115(3):169-72. PubMed ID: 3910330
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime in the therapy of pseudomonal meningitis.
    Marone P; Concia E; Maserati R; Suter F; Minoli L; Andreoni M; Fiori G
    Chemioterapia; 1985 Aug; 4(4):289-92. PubMed ID: 3902257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with ceftazidime of difficult and severe (hospital and non-hospital) infections].
    Sueri L; Scalzini A; Barni C; Chiodera A
    G Ital Chemioter; 1985; 32(2):399-402. PubMed ID: 3914431
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.
    Croisier D; Martha B; Piroth L; Chavanet P
    Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
    Fiori GP; Dietz A; Montanari M; Torre D
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.